New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines

November 19, 2019 09:00:19

The hemp industry has been through a rollercoaster of legislation over the past few years. First, the 2018 Farm Bill made the cultivation of industrial hemp legal, and by extension, making the marketing and sale of hemp-derived CBD legal. This was followed by the USDA’s interim rule on hemp in October 2019 which provided a regulatory framework for the rapidly growing sector.

However, one issue that still plagues the industry is the lack of regulation for CBD products. For long, major players in the industry and other interested parties have decried the lack of control for CBD products, stating that lack of regulation creates…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.